214 related articles for article (PubMed ID: 1944754)
1. Enhancement of ionized calcium and 1,25-dihydroxycholecalciferol loss from peritoneal fluid during peritonitis in patients treated with continuous ambulatory peritoneal dialysis.
Lin CY; Huang TP
Nephron; 1991; 59(1):90-5. PubMed ID: 1944754
[TBL] [Abstract][Full Text] [Related]
2. Losses of 1,25- and 24,25-dihydroxycholecalciferol in the peritoneal fluid of patients treated with continuous ambulatory peritoneal dialysis.
Shany S; Rapoport J; Goligorsky M; Yankowitz N; Zuili I; Chaimovitz C
Nephron; 1984; 36(2):111-3. PubMed ID: 6607420
[TBL] [Abstract][Full Text] [Related]
3. Progress of renal osteodystrophy during continuous ambulatory peritoneal dialysis.
Buccianti G; Bianchi ML; Valenti G
Clin Nephrol; 1984 Dec; 22(6):279-83. PubMed ID: 6525771
[TBL] [Abstract][Full Text] [Related]
4. Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate.
Cho MS; Lee KS; Lee YK; Ma SK; Ko JH; Kim SW; Kim NH; Choi KC
Korean J Intern Med; 2002 Jun; 17(2):114-21. PubMed ID: 12164088
[TBL] [Abstract][Full Text] [Related]
5. Effects of calcifediol treatment on the progression of renal osteodystrophy during continuous ambulatory peritoneal dialysis.
Buccianti G; Bianchi ML; Valenti G; Lorenz M; Cresseri D
Nephron; 1990; 56(4):353-6. PubMed ID: 2079992
[TBL] [Abstract][Full Text] [Related]
6. Renal osteodystrophy in children undergoing continuous ambulatory peritoneal dialysis.
Hewitt IK; Stefanidis C; Reilly BJ; Kooh SW; Balfe JW
J Pediatr; 1983 Nov; 103(5):729-34. PubMed ID: 6631599
[TBL] [Abstract][Full Text] [Related]
7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
8. Losses of 25-hydroxyvitamin D in peritoneal fluid: possible mechanism for bone disease in uremic patients treated with chronic ambulatory peritoneal dialysis.
Aloni Y; Shany S; Chaimovitz C
Miner Electrolyte Metab; 1983; 9(2):82-6. PubMed ID: 6601753
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D and vitamin-D-binding protein kinetics in patients treated with continuous ambulatory peritoneal dialysis (CAPD).
Joffe P; Heaf JG
Perit Dial Int; 1989; 9(4):281-4. PubMed ID: 2488382
[TBL] [Abstract][Full Text] [Related]
10. Low dialysate calcium in continuous ambulatory peritoneal dialysis: a randomized controlled multicenter trial. The Peritoneal Dialysis Multicenter Study Group.
Weinreich T; Passlick-Deetjen J; Ritz E
Am J Kidney Dis; 1995 Mar; 25(3):452-60. PubMed ID: 7872324
[TBL] [Abstract][Full Text] [Related]
11. The effects of intraperitoneal calcitriol on calcium and parathyroid hormone.
Delmez JA; Dougan CS; Gearing BK; Rothstein M; Windus DW; Rapp N; Slatopolsky E
Kidney Int; 1987 Mar; 31(3):795-9. PubMed ID: 3573540
[TBL] [Abstract][Full Text] [Related]
12. Decreased size of peritoneal macrophage during peritonitis in continuous ambulatory peritoneal dialysis patients.
Chen WT; Kobayashi Y; Huang TP; Chiu CC; Lin CY
Am J Nephrol; 1991; 11(5):374-9. PubMed ID: 1809034
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial comparing 1.25 mmol/l calcium dialysate to 1.75 mmol/l calcium dialysate in CAPD patients.
Johnson DW; Rigby RJ; McIntyre HD; Brown A; Freeman J
Nephrol Dial Transplant; 1996 Jan; 11(1):88-93. PubMed ID: 8649658
[TBL] [Abstract][Full Text] [Related]
14. Renal osteodystrophy in children undergoing continuous ambulatory peritoneal dialysis.
Paunier L; Salusky IB; Slatopolsky E; Kangarloo H; Kopple JD; Horst RL; Coburn JW; Fine RN
Pediatr Res; 1984 Aug; 18(8):742-7. PubMed ID: 6472946
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of vitamin D-binding protein and vitamin D metabolite loss in children on continuous ambulatory peritoneal dialysis.
Chen WT; Yamaoka K; Nakajima S; Tanaka Y; Yamamoto T; Satomura K; Okada S; Seino Y
Bone Miner; 1992 Jun; 17(3):389-98. PubMed ID: 1623332
[TBL] [Abstract][Full Text] [Related]
16. Effect of CAPD and hemodialysis on parathyroid function.
Malberti F; Corradi B; Imbasciati E
Adv Perit Dial; 1996; 12():239-44. PubMed ID: 8865912
[TBL] [Abstract][Full Text] [Related]
17. [Dynamic changes in calcium and phosphate plasma concentrations in the patients on peritoneal dialysis].
Jovanović N; Lausević M; Stojimirović B
Vojnosanit Pregl; 2006 Jan; 63(1):27-30. PubMed ID: 16471245
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of calcium carbonate and low-dose vitamin D/1,25(OH)2D3 in reducing the risk of developing renal osteodystrophy in children on continuous ambulatory peritoneal dialysis.
Jüppner H; Hoyer PF; Latta K; Winkler L; Offner G; Brodehl J
Pediatr Nephrol; 1990 Nov; 4(6):614-7. PubMed ID: 2088463
[TBL] [Abstract][Full Text] [Related]
19. Histological renal osteodystrophy, and 25 hydroxycholecalciferol and aluminum levels in patients on continuous ambulatory peritoneal dialysis.
Gokal R; Ramos JM; Ellis HA; Parkinson I; Sweetman V; Dewar J; Ward MK; Kerr DN
Kidney Int; 1983 Jan; 23(1):15-21. PubMed ID: 6834691
[No Abstract] [Full Text] [Related]
20. Calcium kinetic studies in patients on CAPD: improvement of secondary hyperparathyroidism without concomitant improvement of calcium turnover.
Kurz P; Tsobanelis T; Brunkhorst R; Roth P; Werner E; Schoeppe W; Vlachojannis J
Perit Dial Int; 1997; 17(1):59-65. PubMed ID: 9068024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
